Novo Nordisk’s blockbuster diabetes drug Ozempic may reduce the risk of developing Alzheimer’s disease, suggesting its potential to delay or prevent the memory-robbing condition, according to a study… [+4015 chars]Read More
Novo Nordisks diabetes drug Ozempic may reduce the risk of Alzheimers disease study says CNBC
